York-based life sciences business Integumen has announced progress on its COVID-19 wastewater detection system, Microtox PD, in collaboration with Modern Water plc, Avacta Group and Aptamer Group Limited.
Integumen is working with a consortium of companies to find solutions in the fight against the pandemic.
The consortium includes Modern Water, Wetherby-based Avacta, Aptamer and a global provider of innovative technology and services for the data era.
Avacta Group Plc (LON:AVCT) offers reagents and therapeutics based on Affimer technology for diagnostic and research applications in the United Kingdom. The company’s custom Affimer products are also used in drugs and biomarkers discovery in biotech research and development.